about
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthIdentification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HDPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells.Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cells.Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.Human skin dendritic cell fate is differentially regulated by the monocyte identity factor Kruppel-like factor 4 during steady state and inflammation.The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells.Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.Identification of TROP2 (TACSTD2), an EpCAM-like molecule, as a specific marker for TGF-β1-dependent human epidermal Langerhans cells.CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells.Comparative oncology: The paradigmatic example of canine and human mast cell neoplasmsVariability of PD-L1 expression in mastocytosisβ-Catenin promotes the differentiation of epidermal Langerhans dendritic cellsIdentification of a leukemia-initiating stem cell in human mast cell leukemiaImmunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
P50
Q28828739-256A731B-2C5C-42DA-B244-F2053C5F3FFDQ36406996-0878CCE3-62F7-4493-A519-3B2C6269CA18Q36755221-F68FC5A7-98AF-4360-91AC-1063FD3DE7AAQ36977300-30820644-89DD-4D2B-907A-9638B29B7FCDQ37611613-B4A8481E-1D67-41E4-9523-B549C43BC813Q38265115-ABFFE46D-9C52-4716-819D-DE02DC845979Q38812117-9DF81483-9283-4CD8-A9DA-CCDA1187F1A8Q38866094-2DBC7D92-3E6F-4FDE-9E49-BF7E88E71309Q39093823-68FB7135-8DE8-4A61-8A9B-817462182296Q39608346-F77A702D-7D27-4D6B-BFF3-DADEB1F9A20FQ39795335-39E0180A-D7DB-424B-A02F-2E15D80CD08DQ40506431-AA67DF9F-C551-404D-AC08-661F6B44DA28Q41840259-375A4DD3-D6FA-4B90-ABA5-4508356139EEQ47117016-C14FEB44-AB5F-4ABA-A2EA-246392F0FF39Q47653225-E097C21C-CF4A-4E98-8C99-DD0F45451A46Q48010780-F2BD6A9F-63AA-483D-8B9A-F18FA4BE2D41Q48104415-E9105329-9774-4543-B023-C3F64C618868Q50035104-FC4EE54A-3AA5-432D-ADBA-5CA724B804C6Q50623825-887A8C14-9572-4D1A-A8B9-C8BBD675E56CQ51322003-F0A767E5-DAB3-4546-AA7B-29A9EDD94D79Q53119464-3F0AB07F-6001-4EC2-9938-A5BA1B8375D0Q57174064-62AA80A7-C184-4818-88BE-146652EB43E9Q64046290-3D6F50EC-8A99-403E-AEF1-35004DC51AA4Q85883913-44C73448-CE94-4E40-AC33-D4B8537CCD42Q92887046-5099C021-6662-44F9-A452-32DD7DDD4CEAQ93017003-1082C533-6275-4578-9C77-2F2EAA25233F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gregor Eisenwort
@ast
Gregor Eisenwort
@en
Gregor Eisenwort
@es
Gregor Eisenwort
@nl
Gregor Eisenwort
@sl
type
label
Gregor Eisenwort
@ast
Gregor Eisenwort
@en
Gregor Eisenwort
@es
Gregor Eisenwort
@nl
Gregor Eisenwort
@sl
prefLabel
Gregor Eisenwort
@ast
Gregor Eisenwort
@en
Gregor Eisenwort
@es
Gregor Eisenwort
@nl
Gregor Eisenwort
@sl
P106
P31
P496
0000-0003-2735-4645